Loading...
Loading...
India's gabapentin imports from UNITED STATES total $168.3K across 163 shipments from 15 foreign suppliers. PHARMACEUTICAL BUYERS, INC leads with $17.5K in import value; the top 5 suppliers together control 42.3% of this origin. Leading Indian buyers include WATSON PHARMA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for gabapentin — a diversified sourcing base with multiple active suppliers from UNITED STATES.

PHARMACEUTICAL BUYERS, INC is the leading Gabapentin supplier from UNITED STATES to India, with import value of $17.5K across 4 shipments. The top 5 suppliers — PHARMACEUTICAL BUYERS, INC, ACTAVIS ELIZABETH LLC, Actavis Laboratories, UT, Inc, RAFF AND HALL PHARMACY, RAFF & HALL PHARMACY, — collectively account for 42.3% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICAL BUYERS, INC | $17.5K | 4 | 10.4% |
| 2 | ACTAVIS ELIZABETH LLC | $16.6K | 54 | 9.9% |
| 3 | Actavis Laboratories, UT, Inc | $14.0K | 4 | 8.3% |
| 4 | RAFF AND HALL PHARMACY | $12.5K | 2 | 7.4% |
| 5 | RAFF & HALL PHARMACY, | $10.7K | 1 | 6.3% |
| 6 | Good Health Pharma Supplies | $10.6K | 1 | 6.3% |
| 7 | TEVA EDISON PACKAGING | $9.3K | 4 | 5.5% |
| 8 | PRINSTON PHARMACEUTICAL INC. | $7.9K | 1 | 4.7% |
| 9 | ESPEE BIOPHARMA & FINECHEM LLC | $7.7K | 1 | 4.6% |
| 10 | TIME-CAP LABS, INC. | $7.3K | 1 | 4.3% |
| 11 | NEW LIFE MEDICALS LLC., | $6.8K | 1 | 4.1% |
| 12 | BIONPHARMA INC | $6.3K | 5 | 3.7% |
| 13 | AMSTERDAM PHARMA(APTEKA RX INC) | $5.6K | 3 | 3.3% |
| 14 | ILAPO-INTERNATIONALE LUDWIGS- | $4.6K | 1 | 2.7% |
| 15 | AMNEAL LLC | $4.4K | 20 | 2.6% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | WATSON PHARMA PRIVATE LIMITED | $49.1K | 16 | 29.1% |
| 2 | XYLOPIA LABS PRIVATE LIMITED | $20.9K | 6 | 12.4% |
| 3 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $16.4K | 53 | 9.7% |
| 4 | AJANTA PHARMA LIMITED | $12.5K | 2 | 7.4% |
| 5 | CLIANTHA RESEARCH LIMITED | $11.8K | 2 | 7.0% |
| 6 | HETERO LABS LIMITED | $10.6K | 1 | 6.3% |
| 7 | MARKSANS PHARMA LIMITED | $7.3K | 1 | 4.3% |
| 8 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $6.8K | 30 | 4.1% |
| 9 | MICRO LABS LIMITED | $6.8K | 1 | 4.1% |
| 10 | NUWILL RESEARCH AND INNOVATIONS PRIVATE LIMITED | $6.3K | 5 | 3.7% |
| 11 | AXXELENT PHARMA SCIENCE PRIVATE LIMITED | $5.6K | 3 | 3.3% |
| 12 | AUROBINDO PHARMA LTD | $5.1K | 3 | 3.0% |
| 13 | ORBION PHARMACEUTICALS PRIVATE LIMITED | $3.7K | 1 | 2.2% |
| 14 | GRAVITI PHARMACEUTICALS PRIVATE LIMITED | $2.5K | 10 | 1.5% |
| 15 | THE MADRAS PHARMACEUTICALS | $825 | 1 | 0.5% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Gabapentin suppliers from UNITED STATES to India include PHARMACEUTICAL BUYERS, INC, ACTAVIS ELIZABETH LLC, Actavis Laboratories, UT, Inc. The leading supplier is PHARMACEUTICAL BUYERS, INC with import value of $17.5K USD across 4 shipments. India imported Gabapentin worth $168.3K USD from UNITED STATES in total across 163 shipments.
India imported Gabapentin worth $168.3K USD from UNITED STATES across 163 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Gabapentin sourced from UNITED STATES include WATSON PHARMA PRIVATE LIMITED, XYLOPIA LABS PRIVATE LIMITED, ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED. The largest buyer is WATSON PHARMA PRIVATE LIMITED with $49.1K in imports across 16 shipments.
The total value of Gabapentin imports from UNITED STATES to India is $168.3K USD, across 163 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
163 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists